Companies
KULR Secures $30 Million Battery Supply Deal, Accelerating U.S. Energy Storage Expansion
Five-year agreement with Caban Energy strengthens domestic manufacturing and positions KULR at the center of mission-critical power infrastructure. KULR Technology...
XTL Biopharmaceuticals Makes Bold Bet on Autism Breakthrough with NeuroNOS Acquisition
Transformative deal targets the biological roots of autism, opening a new frontier in disease-modifying therapy. XTL Biopharmaceuticals has taken a...
Google Joins the $4 Trillion Club as AI Boom Rewrites Big Tech’s Power Rankings
Surging Gemini adoption and custom chip deals propel Alphabet into rarefied territory—just behind Nvidia. Google has officially entered one of...
Paramount Skydance Escalates Showdown for Warner Bros. in High-Stakes Streaming War
Legal action, boardroom battles, and a rival Netflix bid push Hollywood’s biggest takeover fight to a breaking point. The battle...
AZIO AI Secures $107 Million Government GPU Deal, Signaling a New Era for AI Infrastructure in Southeast Asia
Landmark Nvidia B300 order and expanding public-sector pipeline position AZIO AI as a rising force in sovereign AI computing AZIO...
AI’s Power Hunger Sparks Nuclear Revival as Tech Turns to Long-Term Energy Deals
Meta’s nuclear agreements send Oklo and Vistra soaring, signaling a broader shift in how data centers fuel the AI boom...
Rick Sparkle Holdings Soars 115% as Speculation and Momentum Collide
Thin float, heavy volume, and catalyst-driven trading ignite a sharp rally in ANPA shares Shares of Rick Sparkle Holdings (ANPA)...
flyExclusive Elevates Private Aviation Connectivity With Starlink Deal
Authorized dealership positions the jet operator at the forefront of in-flight internet and MRO services flyExclusive (FLYX) is raising the...
UnitedHealth’s Road to $500: Why the Healthcare Giant Could Rally Over the Next 12–14 Months
From turnaround strategies to long-term growth drivers, UNH may be poised for a powerful rebound as market sentiment shifts UnitedHealth...
Alumis Breaks Out With Promising Psoriasis Data
Envudeucitinib positions the biotech for a high-stakes TYK2 showdown heading into 2026 Biotech stock Alumis (ALMS) surged more than 110%...
